1. Home
  2. VTYX vs BKSY Comparison

VTYX vs BKSY Comparison

Compare VTYX & BKSY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ventyx Biosciences Inc.

VTYX

Ventyx Biosciences Inc.

HOLD

Current Price

$7.82

Market Cap

713.6M

Sector

Health Care

ML Signal

HOLD

Logo BlackSky Technology Inc.

BKSY

BlackSky Technology Inc.

HOLD

Current Price

$17.52

Market Cap

658.3M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
VTYX
BKSY
Founded
2018
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
713.6M
658.3M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
VTYX
BKSY
Price
$7.82
$17.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
5
Target Price
$14.60
$29.00
AVG Volume (30 Days)
1.8M
1.5M
Earning Date
11-06-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$101,731,000.00
Revenue This Year
N/A
$8.51
Revenue Next Year
N/A
$31.31
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.78
$6.15
52 Week High
$10.55
$33.20

Technical Indicators

Market Signals
Indicator
VTYX
BKSY
Relative Strength Index (RSI) 42.39 47.91
Support Level $7.94 $16.34
Resistance Level $8.52 $18.33
Average True Range (ATR) 0.58 1.37
MACD -0.23 0.07
Stochastic Oscillator 5.44 35.35

Price Performance

Historical Comparison
VTYX
BKSY

About VTYX Ventyx Biosciences Inc.

Ventyx Biosciences Inc is a clinical-stage biopharmaceutical company focused on advancing new therapies for millions of patients living with inflammatory diseases and autoimmune, and neurodegenerative disorders. The company is developing a pipeline of novel small-molecule product candidates to address a range of inflammatory diseases. Its product candidate VTX958 is an oral, selective clinical-stage tyrosine kinase type 2 (TYK2) inhibitor designed to inhibit TYK2 without detectable inhibition of other Janus kinase (JAK) isoforms, which avoids toxicities associated with broader JAK inhibition and, thus, other JAK inhibitors.

About BKSY BlackSky Technology Inc.

BlackSky Technology Inc is a provider of real-time geospatial intelligence. The company delivers on-demand, high-frequency imagery, monitoring, and analytics of some of the critical and strategic locations, economic assets, and events in the world. It designs, owns, and operates one of the industry's low earth orbit (LEO) small satellite constellations, optimized to capture imagery cost-efficiently where and when its customers need it. its Spectra AI software platform processes data from BlackSky's constellation and other third-party sensors to develop the critical insights and analytics that provide its customers with the actionable intelligence. Geographically, the company operates in North America, the Middle East, Asia, and Others.

Share on Social Networks: